Editas Medicine Inc buy Slaandjivaa
Start price
22.01.18
/
50%
€30.80
Target price
23.07.18
€34.28
Performance (%)
6.15%
End price
23.07.18
€32.70
Summary
This prediction ended on 23.07.18 with a price of €32.70. The BUY prediction by Slaandjivaa finished with a performance of 6.15%. Slaandjivaa has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Editas Medicine Inc | -6.349% | -6.349% | -11.875% | -69.627% |
| iShares Core DAX® | 2.992% | 3.220% | 4.271% | 53.697% |
| iShares Nasdaq 100 | -1.584% | -3.172% | 24.749% | 76.697% |
| iShares Nikkei 225® | -2.254% | -9.924% | 43.518% | 60.793% |
| iShares S&P 500 | -0.009% | 1.641% | 20.967% | 62.807% |
Comments by Slaandjivaa for this prediction
In the thread Editas Medicine Inc diskutieren
Edit besser als Crispr?
(Laufzeit überschritten)